Navigation Links
Study to Investigate AHCC and the Swine Flu Virus
Date:6/1/2009

Prior studies published in peer-reviewed journals have shown the benefits of AHCC against influenza, avian flu, west nile virus and MRSA.

BEAVERTON, Ore., June 1 /PRNewswire/ -- A study evaluating the effect of AHCC (Active Hexose Correlated Compound) on supporting the immune system in response to the swine flu virus will be conducted at the Southern China Agricultural University, one of the few research centers in China that have been approved to conduct studies on highly infectious diseases such as the swine flu. This controlled study will examine the effects of AHCC when supplemented to a group of mice infected with the virus.

Two years ago, following the avian flu outbreak, the same university conducted a study in mice on the effect of AHCC on the bird flu (H5N1) virus. The findings, published in the Japanese Journal of Complementary and Alternative Medicine (Vol. 4, (2007), No. 1 pp. 37-40), demonstrated that AHCC enhanced host resistance against bird flu. Other papers published in peer-reviewed journals include studies on AHCC and the common influenza (H1N1), the West Nile Virus and hospital-borne infections including MRSA.

"The animal study published by my group in the recent issue of Journal of Nutrition suggested that dietary supplementation with AHCC may be immunotherapeutic for the West-Nile Virus potentially susceptible populations." said Tian Wang, Assistant Professor at the Departments of Microbiology, Immunology and Pathology at the University of Texas Medical Branch at Galveston. "So in light of our findings and similar conclusions of Drexel University's study on influenza, I think that a study on AHCC and the swine flu is very timely and likely to yield useful information on the value of AHCC in combating this virus".

Published human clinical studies have shown that AHCC activates NK cells and DC Cells, which are the body's frontline defense against viruses and infections. A recent study at the Yale Medical School also showed that AHCC increases the production of cytokines which act as chemical messengers that activate the immune system when the body comes under attack.

"AHCC is the only natural compound that I know of which has been studied not only for influenza but also for several other important virus strains." said Fred Pescatore, MD, MPH of the Center for Integrative and Complementary Medicine. "The combination of the animal research on those specific strains and the significant clinical data on the efficacy of AHCC in humans makes this compound a very compelling target for further research specifically against the swine flu."

What is AHCC (Active Hexose Correlated Compound)?

AHCC is a natural compound derived from the hybridization of several subspecies of medicinal mushroom. AHCC is used by hundreds of healthcare facilities around the world and by hospitals as a part of a standard regimen for incoming patients to reduce the risk of hospital infections. AHCC is supported by more than 20 studies published in major peer-reviewed medical journals (key term "active hexose correlated compound" at www.PubMed.org).

To learn more about AHCC, please visit the AHCC Research Association Website at www.AHCCresearch.org.


'/>"/>
SOURCE AHCC Research Association
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New Study Documents High Prevalence of Serious Mental Illnesses Among Nations Jail Populations
2. New Market Research Study Shows Lung Cancer Treatments Differ Significantly by Both Age and Geography
3. Study shows gay couples want legal rights, regardless of marriage
4. Hopkins study: When adult patients have anxiety disorder, their children need help too
5. Study shows drug combination improves outcome for advanced non-small cell lung cancer
6. New Study Shows Probiotics Linked to Metabolism
7. New study indicates that parents influence on childrens eating habits is small
8. Student Veteran Health Examined in First-of-Its-Kind Study by University of Minnesota/Minnesota State Colleges and Universities
9. Music may improve feeding, reduce pain in premature babies: U of A study
10. Study Finds Multitude of Bacteria on Human Skin
11. Cancer Survivors Can Still Be Fit, Study Asserts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/7/2016)... ... February 07, 2016 , ... Dr. ... Kybella® to his medical and surgical expertise. Technically known as deoxycholic acid or ... used as a non-surgical alternative for reduction of fat below the chin (aka ...
(Date:2/6/2016)... , ... February 06, 2016 , ... Shark Finds ... announce the launch of a new DRTV campaign with Belly Bands. , Having a ... everything from sprays to puppy pads and find nothing works, get Belly Bands, ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... the availability of the company's lighter, sleeker next generation LYNX VR Indoor Trainer ... , Improvements in design and manufacturing not only reduce the weight of ...
(Date:2/5/2016)... , ... February 05, 2016 , ... ... domestic franchisees of Popeyes Louisiana Kitchen restaurants, launched the 14th annual “Appetite for ... kids and adults with muscular dystrophy, ALS and related diseases that severely limit ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... After years ... General Hospital Burn Unit, plastic and cosmetic surgeon Dr. Wayne Carman transitioned to chief ... Hospital. He successfully completed his first three-year term as chief and began a second ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... , Feb. 5, 2016  As people age, it ... multitude of recommended screenings and tests that are linked ... priority. However, for the majority of aging individuals, hearing ... planning. For the 37.5 million American adults who report ... present to make hearing health a 2016 healthy aging ...
(Date:2/5/2016)... , Feb. 5, 2016  Aralez Pharmaceuticals Inc. ... of POZEN Inc. ("POZEN") and Tribute Pharmaceuticals Canada Inc. ("Tribute") ... and shareholders of Tribute. The combined company will operate ... company with operations in Canada , ... United States . Under the terms of the ...
(Date:2/5/2016)... , Feb. 5, 2016 Aethlon Medical, Inc. (Nasdaq: ... Chairman and CEO, will be presenting at Source Capital Group,s ... York, NY at 2:15 p.m. ET on Wednesday, ... Immunotherapy Panel discussion taking place at 3:15 p.m. ET. ... approximately one hour after the conclusion of the live event. ...
Breaking Medicine Technology: